Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Top 10 Drugs Of 2020: #3 Revlimid

The Patent Cliff Looms

23 Apr 2021

• By Derek Burkhard, Daniel Chancellor, and Stephanie Yip

Related Content

BMS Revenues Soar, But High-Flying Revlimid Is A Big Driver

05 Feb 2021

BMS/Bluebird Ready Abecma, First BCMA-Targeting CAR-T, For Initial Patients

30 Mar 2021

With Celgene Acquisition Closed, Bristol Faces Major Milestones

22 Nov 2019

The Top 10 Best-Selling Drugs of 2019

12 Aug 2020

Related Companies

Celgene Corporation

Bristol Myers Squibb Company

Additional Topics

Commercial Sales & Earnings Business Strategies BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.